Semi-Annual Consolidated Statement Of Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7576995

Concept 2022-04-01 to
2022-12-31
2021-04-01 to
2021-12-31
Semi-annual consolidated statement of income
Statement of income
Net sales
5,229,000 JPY
330,000 JPY
Cost of sales
1,282,000 JPY
82,000 JPY
Gross profit (loss)
3,946,000 JPY
247,000 JPY
Ordinary profit (loss)
-1,223,957,000 JPY
-1,076,020,000 JPY
Extraordinary income
JPY
4,468,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
1,222,318,000 JPY
1,073,965,000 JPY
Extraordinary losses
JPY
5,301,000 JPY
Profit (loss) before income taxes
-1,223,957,000 JPY
-1,076,854,000 JPY
Operating profit (loss)
-1,218,371,000 JPY
-1,073,717,000 JPY
Income taxes - current
1,425,000 JPY
1,815,000 JPY
Non-operating income
Interest income
11,000 JPY
14,000 JPY
Non-operating income
557,000 JPY
103,000 JPY
Non-operating expenses
Non-operating expenses
6,144,000 JPY
2,407,000 JPY
Income taxes
1,425,000 JPY
1,815,000 JPY
Profit (loss)
-1,225,382,000 JPY
-1,078,669,000 JPY
Extraordinary income
Gain on sale of non-current assets
JPY
13,000 JPY
Extraordinary losses
Impairment losses
JPY
5,264,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.